{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:22:13Z","timestamp":1760980933005},"reference-count":42,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2005,10,13]],"date-time":"2005-10-13T00:00:00Z","timestamp":1129161600000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Nephrology"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:p><jats:bold>SUMMARY:\u2003<\/jats:bold> With the introduction of the calcimimetic cinacalcet HCl, some patients who would previously have undergone parathyroidectomy are likely to remain on medical therapy. Data is available on complication rates and some important outcome measures of parathyroidectomy, but the efficacy of calcimimetics to influence patient\u2010based endpoints such as cardiovascular mortality and renal osteodystrophy has not been established. Nevertheless, cinacalcet HCl has been demonstrated to improve levels of calcium, phosphate, the calcium phosphate product and parathyroid hormone (PTH). Based on available data, parathyroidectomy is proposed as the preferred treatment option when averaged levels of intact PTH (iPTH) exceed 85\u201395\u2003pmol\/L despite optimal therapy. When iPTH levels exceed 50\u2003pmol\/L, parathyroidectomy should be considered if levels of serum calcium, phosphate or the calcium phosphate product are above established target ranges or when patients with established osteoporosis have progressive loss of bone mineral density. Because the currently\u2010recommended biochemical targets are difficult to achieve and maintain for many patients on dialysis, parathyroidectomy rates are likely to increase if these management proposals are followed. This highlights the need for prospective studies with \u2018hard\u2019 endpoints, to establish evidence\u2010based roles for parathyroidectomy and calcimimetic therapy.<\/jats:p>","DOI":"10.1111\/j.1440-1797.2005.00476.x","type":"journal-article","created":{"date-parts":[[2005,10,13]],"date-time":"2005-10-13T07:50:52Z","timestamp":1129189852000},"page":"511-515","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Parathyroidectomy in the calcimimetic era"],"prefix":"10.1111","volume":"10","author":[{"given":"GRAHAME J","family":"ELDER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,10,13]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(04)01103-5"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.67139.x"},{"key":"e_1_2_8_4_2","first-page":"S56","article-title":"K\/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease","volume":"42","author":"NKF.","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.63.s85.26.x"},{"key":"e_1_2_8_6_2","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO (4), Ca x PO (4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh SK","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_2_8_7_2","first-page":"SU","article-title":"Attainment of proposed NKF\u2010K\/DOQI PTH and calcium x phosphate targets is associated with decreased mortality risk in hemodialysis patients","author":"Walters BAJ","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000133041.27682.A2"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.87.7.e10"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.27394"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.66015.x"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(200007)184:1<37::AID-JCP4>3.0.CO;2-M"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12710-9"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.17.6.1135"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00368.x"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1995.01430060081015"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200101000-00011"},{"key":"e_1_2_8_18_2","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1681\/ASN.V341008","article-title":"Short\u2010 and long\u2010term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients","volume":"3","author":"Gagne ER","year":"1992","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.63.s85.23.x"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00972.x"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/77.2.1175"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000045976"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(01)00865-0"},{"key":"e_1_2_8_24_2","first-page":"878","article-title":"Improved health\u2010related quality of life and left ventricular hypertrophy among dialysis patients treated with parathyroidectomy","volume":"16","author":"Chow KM","year":"2003","journal-title":"J. Nephrol."},{"issue":"3","key":"e_1_2_8_25_2","first-page":"47","article-title":"Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism","volume":"18","author":"Nakanishi S","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1774-9987.2005.00214.x"},{"issue":"3","key":"e_1_2_8_27_2","first-page":"31","article-title":"Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients","volume":"18","author":"Fukagawa M","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg586"},{"issue":"3","key":"e_1_2_8_29_2","first-page":"50","article-title":"Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patients","volume":"18","author":"Yamamoto H","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2000.00370.x"},{"issue":"3","key":"e_1_2_8_31_2","first-page":"9","article-title":"Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor and cyclin\u2010dependent kinase inhibitors, p21 and p27","volume":"18","author":"Tokumoto M","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2388(199703\/04)13:2<78::AID-SSU3>3.0.CO;2-Z"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1159\/000188261"},{"key":"e_1_2_8_34_2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1681\/ASN.V1341017","article-title":"The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism","volume":"13","author":"Goodman WG","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000050224.03126.AD"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00720.x"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031633"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004060512"},{"key":"e_1_2_8_39_2","first-page":"MO17","article-title":"The effect of cinacalcet HCl on parathyroidectomy, fracture, hospitalization, and mortality in dialysis subjects with secondary hyperparathyroidism (HPT)","author":"Cunningham J","year":"2004","journal-title":"EDTA"},{"key":"e_1_2_8_40_2","first-page":"MO16","article-title":"Cinacalcet HCl reduces bone turnover and bone marrow fibrosis in hemodialysis patients with secondary hyperparathyroidism (HPT)","author":"Malluche HH","year":"2004","journal-title":"EDTA"},{"key":"e_1_2_8_41_2","first-page":"PUB479","article-title":"Preliminary results from TARGET: Treatment strategies to achieve recommended K\/DOQI\u2122 goals in ESRD patients on cinacalcet","author":"Chertow GM","year":"2004","journal-title":"American Society of Nephrology Renal Week"},{"key":"e_1_2_8_42_2","first-page":"F","article-title":"The CONTROL STUDY: enhanced achievement of NKF\u2010K\/DOQI\u2122 bone metabolism and disease targets using cinacalcet HCl (Sensipar\u2122)","author":"Reed J","year":"2004","journal-title":"American Society of Nephrology Renal Week"},{"key":"e_1_2_8_43_2","unstructured":"The CARI guidelines (Caring for Australians with Renal Impairment). Available from:http:\/\/www.kidney.org.au\/cari\/index.php"}],"container-title":["Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1797.2005.00476.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1797.2005.00476.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T08:23:00Z","timestamp":1695889380000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1797.2005.00476.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1111\/j.1440-1797.2005.00476.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1797.2005.00476.x","archive":["Portico"],"relation":{},"ISSN":["1320-5358","1440-1797"],"issn-type":[{"value":"1320-5358","type":"print"},{"value":"1440-1797","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"2005-10-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}